Viewing Study NCT00133315



Ignite Creation Date: 2024-05-05 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00133315
Status: COMPLETED
Last Update Posted: 2007-04-10
First Post: 2005-08-22

Brief Title: TNFalfa Blocking Treatment of Spondylarthropathies
Sponsor: Hvidovre University Hospital
Organization: Hvidovre University Hospital

Study Overview

Official Title: TNFalfa Blocking Treatment of Spondylarthropathies - A Danish Multicenter Study of New Methods for Better Monitoring and Prognostifying Patients With Spondylarthropathies
Status: COMPLETED
Status Verified Date: 2007-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the study is to establish a Danish cohort of spondylarthropathy SpA patients who are being treated with TNFalfa blockers By following the TNFalfa blocking treated patients the researchers want to identify better biomarkers for disease activity and disease progression In addition the researchers want to identify predictors for disease progression
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
KF 02-05004 None None None